Skip to main content
Caplight Logo









Complement 1

Complement 1

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.complement1.com/

Last Round

Seed

May 13, 2025

Est. Valuation

$60M

Total Funding Raised

$16M

Company Overview

Complement 1 is a health technology company that provides a tech-enabled, clinically validated lifestyle modification platform with one-on-one coaching for cancer patients and high-risk individuals.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Medical AI, Telemedicine, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

oncology supportcancer care platformlifestyle modificationdigital health coachingpatient engagement softwareclinical decision supporthealth techdigital therapeuticsDTxpersonalized oncologycare pathway managementB2B health techvirtual carecancer survivorshipvalue-based care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Complement 1 Comparables

Compare Complement 1 with similar companies based on industry and business-model similarity.

Complement 1 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Osara Health
84%
Jasper Health
82%
OncoveryCare
78%

Complement 1 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 13, 2025

Key People

Founding team and executive leadership

Trupti Mukker

Co-Founder And COO

Founding Team

Pranab Dash

CTO

Executive Team

Complement 1 Investors

Notable investors and investment history

Complement 1 investors
InvestorRounds
Owl VenturesSeed
Blume VenturesSeed
Owl VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 13, 2025

    $16M round led by Blume Ventures and Owl Ventures.

Complement 1 Filings

Explore SEC and related filing metadata, where available.

Complement 1 filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Complement 1's valuation, stock price, and market status.

Is Complement 1 a public or private company?

Complement 1 is a private company.

What is the current stock price of Complement 1?

Complement 1 is a private company with no public stock price. No recent secondary market data is available.

How much is Complement 1 worth (valuation)?

Valuation information for Complement 1 is not publicly available.

Can I buy Complement 1 stock?

Complement 1 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Complement 1's last funding round?

Complement 1's most recent funding round was Seed on May 13, 2025.

Who are the main investors in Complement 1?

Key investors in Complement 1 include Owl Ventures, Blume Ventures.

Will Complement 1 IPO soon?

No public IPO plans have been announced for Complement 1.

How can I track Complement 1 secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Complement 1's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range12
Year Founded2024
Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?